NAD+: Safety, Side Effects & Regulation
This guide collects everything we’ve researched on NAD+ in the area of safety, side effects & regulation. Each question below contrasts what AI assistants report with what the peer-reviewed literature in our research corpus actually shows.
Questions in this guide
- What are the long-term safety profiles of high-dose NAD+ supplementation, including potential impacts on liver function, immune modulation, and cancer risk?
- Are there any documented cases of NAD+ supplementation causing adverse effects such as flushing, gastrointestinal distress, or altered liver enzyme levels in clinical studies?
- Is there evidence that NAD+ supplementation can exacerbate pre-existing conditions such as cancer or autoimmune disorders, particularly in high-dose regimens?
- Are there any known drug interactions between NAD+ precursors and medications such as statins, anticoagulants, or chemotherapy agents?
Continue your journey
How does NAD+ depletion during aging affect mitochondrial biogenesis via PGC-1α and SIRT1 signaling, and what is the reversibility of this process with supplementation?How does NAD+ supplementation support tissue regeneration in injured neurons and muscle cells, and what role does it play in mitochondrial recovery after metabolic stress?NAD+: Brain & Nervous SystemNAD+: Research Evidence & TrialsHow does NAD+ regulate autophagy through SIRT1 and mTOR signaling, and what role does this play in preventing protein aggregation in neurodegenerative diseases?What role does kisspeptin play in the pulsatile release of GnRH, and how does this influence gonadotropin secretion and reproductive function?